Cleveland BioLabs, Inc. (NASDAQ:CBLI) went up by 37.79% from its latest closing price when compared to the 1-year high value of $5.00 and move down -110.97%, while CBLI stocks collected +27.54% of gains with the last five trading sessions. Press Release reported on 06/03/20 that Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules

Cleveland BioLabs, Inc. (NASDAQ:CBLI) Worth an Investment?

Cleveland BioLabs, Inc. (NASDAQ: CBLI) The 36 Months beta value for CBLI stocks is at 0.93, while of the analysts out of 0 who provided ratings for Cleveland BioLabs, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $40.00 which is -$0.37 below current price. CBLI currently has a short float of 0.34% and public float of 5.58M with average trading volume of 282.71K shares.

CBLI Market Performance

CBLI stocks went down by -1.15% for the week, with the monthly drop of -17.31% and a quarterly performance of 1.78%, while its annual performance rate touched 11.69%. The simple moving average for the period of the last 20 days is 42.42% for CBLI stocks with the simple moving average of 61.68% for the last 200 days.

Analysts’ Opinion on Cleveland BioLabs, Inc. (NASDAQ:CBLI)

Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see CBLI stock at the price of $4. The rating they have provided for CBLI stocks is “Buy” according to the report published on March 21, 2013.

Oppenheimer gave “Outperform” rating to CBLI stocks, setting the target price at $3 in the report published on December 6, 2012.

CBLI Stocks 34.38% Far from 50 Day Moving Average

After a stumble in the market that brought CBLI to its low price for the period of the last 52 weeks, Cleveland BioLabs, Inc. was unable to take a rebound, for now settling with -52.60% of loss for the given period.

The stock volatility was left at 9.57%, however, within the period of a single month, the volatility rate increased by 8.94%, while the shares surge at the distance of +3.90% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +35.67% upper at the present time.

In the course of the last 5 trading sessions, CBLI went up by +27.54%, which changed the moving average for the period of 200 days to the total of +76.08% of gains for the stock in comparison to the 20-day moving average settled at $1.6681. In addition, Cleveland BioLabs, Inc. saw 185.71% in overturn over the period of a single year with a tendency to cut further gains.

CBLI Stock Fundamentals

The current profitability levels are settled at -212.03 for the present operating margin. The net margin for Cleveland BioLabs, Inc. stands at -237.73. Equity return holds the value 63.00%, with -102.50% for asset returns.